B

BioPorto Diagnostics A/S

45 employees

BioPorto Diagnostics offers a wide range of diagnostic tests and antibodies to healthcare professionals in clinical and research settings.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
NGAL ELISA kits (human and animal
generic Rapid Assay Device (gRAD)
non-clinical research
NGAL biomarker
Appetite Regulating Hormones
Complement and Innate Immunity
clinical research
research & development
Assay Development
Health Diagnostics
pre-clinical
FDA Qualified Biomarker (BQP)
Health Care
In-vitro Diagnostics (IVD)
Antibodies
scientific and pre-clinical drug research
Lateral flow assay development (gRAD)
Clinical research
diagnostics
drug induced kidney injury (DIKI)
Acute kidney injury (AKI) biomarker

Date founded

1995

FAQ